▶ 調査レポート

ペルツズマブの世界市場 2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Pertuzumab Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。ペルツズマブの世界市場 2020年:メーカー別、地域別、種類・用途別 / Global Pertuzumab Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D005-12005資料のイメージです。• レポートコード:D005-12005
• 出版社/出版日:GlobalInfoResearch / 2020年5月
• レポート形態:英文、PDF、102ページ
• 納品方法:Eメール(納期2~3日)
• 産業分類:医療・製薬
• 販売価格(消費税別)
  Single User¥448,920 (USD3,480)▷ お問い合わせ
  Multi User¥673,380 (USD5,220)▷ お問い合わせ
  Corporate User¥897,840 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ペルツズマブの世界市場を広く調査・分析し、今後の市場展望をまとめております。ペルツズマブの種類別市場規模(ヒト由来、動物由来)、用途別市場規模(病院、医療センター)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Novartis AG、InvivoGen、Pfizer、Bio-Techne、Abnova Corporation、Biocon Limited、Celltrion
・地域別グローバル市場分析 2015年-2020年
・ペルツズマブの北米市場(アメリカ、カナダ、メキシコ)
・ペルツズマブのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ペルツズマブのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ペルツズマブの南米市場(ブラジル、アルゼンチン)
・ペルツズマブの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:ヒト由来、動物由来
・用途別分析:病院、医療センター
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The global Pertuzumab market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Pertuzumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Pertuzumab market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Pertuzumab market has been segmented into
Human Source
Animal Source

By Application, Pertuzumab has been segmented into:
Hospital
Medical Center

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pertuzumab market presented in the report. This section sheds light on the sales growth of different regional and country-level Pertuzumab markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pertuzumab market.

The report offers in-depth assessment of the growth and other aspects of the Pertuzumab market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Pertuzumab Market Share Analysis
Pertuzumab competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pertuzumab sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pertuzumab sales, revenue and market share for each player covered in this report.

The major players covered in Pertuzumab are:
Novartis AG
InvivoGen
Pfizer
Bio-Techne
Abnova Corporation
Biocon Limited
Celltrion

Among other players domestic and global, Pertuzumab market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pertuzumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pertuzumab, with price, sales, revenue and global market share of Pertuzumab in 2018 and 2019.
Chapter 3, the Pertuzumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pertuzumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Pertuzumab market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Pertuzumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

Table of Contents

1 Market Overview
1.1 Pertuzumab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pertuzumab Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Human Source
1.2.3 Animal Source
1.3 Market Analysis by Application
1.3.1 Overview: Global Pertuzumab Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Medical Center
1.4 Overview of Global Pertuzumab Market
1.4.1 Global Pertuzumab Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis AG
2.1.1 Novartis AG Details
2.1.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novartis AG SWOT Analysis
2.1.4 Novartis AG Product and Services
2.1.5 Novartis AG Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 InvivoGen
2.2.1 InvivoGen Details
2.2.2 InvivoGen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 InvivoGen SWOT Analysis
2.2.4 InvivoGen Product and Services
2.2.5 InvivoGen Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Pfizer SWOT Analysis
2.3.4 Pfizer Product and Services
2.3.5 Pfizer Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bio-Techne
2.4.1 Bio-Techne Details
2.4.2 Bio-Techne Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bio-Techne SWOT Analysis
2.4.4 Bio-Techne Product and Services
2.4.5 Bio-Techne Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Abnova Corporation
2.5.1 Abnova Corporation Details
2.5.2 Abnova Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Abnova Corporation SWOT Analysis
2.5.4 Abnova Corporation Product and Services
2.5.5 Abnova Corporation Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biocon Limited
2.6.1 Biocon Limited Details
2.6.2 Biocon Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biocon Limited SWOT Analysis
2.6.4 Biocon Limited Product and Services
2.6.5 Biocon Limited Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Celltrion
2.7.1 Celltrion Details
2.7.2 Celltrion Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Celltrion SWOT Analysis
2.7.4 Celltrion Product and Services
2.7.5 Celltrion Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Pertuzumab Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Pertuzumab Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Pertuzumab Manufacturer Market Share in 2019
3.3.2 Top 6 Pertuzumab Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Pertuzumab Sales, Revenue and Market Share by Regions
4.1.1 Global Pertuzumab Sales and Market Share by Regions (2015-2020)
4.1.2 Global Pertuzumab Revenue and Market Share by Regions (2015-2020)
4.2 North America Pertuzumab Sales and Growth Rate (2015-2020)
4.3 Europe Pertuzumab Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Pertuzumab Sales and Growth Rate (2015-2020)
4.5 South America Pertuzumab Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Pertuzumab Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Pertuzumab Sales, Revenue and Market Share by Country
5.1.1 North America Pertuzumab Sales and Market Share by Country (2015-2020)
5.1.2 North America Pertuzumab Revenue and Market Share by Country (2015-2020)
5.2 United States Pertuzumab Sales and Growth Rate (2015-2020)
5.3 Canada Pertuzumab Sales and Growth Rate (2015-2020)
5.4 Mexico Pertuzumab Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Pertuzumab Sales, Revenue and Market Share by Country
6.1.1 Europe Pertuzumab Sales and Market Share by Country (2015-2020)
6.1.2 Europe Pertuzumab Revenue and Market Share by Country (2015-2020)
6.2 Germany Pertuzumab Sales and Growth Rate (2015-2020)
6.3 UK Pertuzumab Sales and Growth Rate (2015-2020)
6.4 France Pertuzumab Sales and Growth Rate (2015-2020)
6.5 Russia Pertuzumab Sales and Growth Rate (2015-2020)
6.6 Italy Pertuzumab Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Pertuzumab Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Pertuzumab Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Pertuzumab Revenue and Market Share by Regions (2015-2020)
7.2 China Pertuzumab Sales and Growth Rate (2015-2020)
7.3 Japan Pertuzumab Sales and Growth Rate (2015-2020)
7.4 Korea Pertuzumab Sales and Growth Rate (2015-2020)
7.5 India Pertuzumab Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Pertuzumab Sales and Growth Rate (2015-2020)
7.7 Australia Pertuzumab Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Pertuzumab Sales, Revenue and Market Share by Country
8.1.1 South America Pertuzumab Sales and Market Share by Country (2015-2020)
8.1.2 South America Pertuzumab Revenue and Market Share by Country (2015-2020)
8.2 Brazil Pertuzumab Sales and Growth Rate (2015-2020)
8.3 Argentina Pertuzumab Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Pertuzumab Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Pertuzumab Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Pertuzumab Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Pertuzumab Sales and Growth Rate (2015-2020)
9.3 Turkey Pertuzumab Sales and Growth Rate (2015-2020)
9.4 Egypt Pertuzumab Sales and Growth Rate (2015-2020)
9.5 South Africa Pertuzumab Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Pertuzumab Sales and Market Share by Type (2015-2020)
10.2 Global Pertuzumab Revenue and Market Share by Type (2015-2020)
10.3 Global Pertuzumab Price by Type (2015-2020)
11 Global Pertuzumab Market Segment by Application
11.1 Global Pertuzumab Sales Market Share by Application (2015-2020)
11.2 Global Pertuzumab Revenue Market Share by Application (2015-2020)
11.3 Global Pertuzumab Price by Application (2015-2020)
12 Market Forecast
12.1 Global Pertuzumab Sales, Revenue and Growth Rate (2021-2025)
12.2 Pertuzumab Market Forecast by Regions (2021-2025)
12.2.1 North America Pertuzumab Market Forecast (2021-2025)
12.2.2 Europe Pertuzumab Market Forecast (2021-2025)
12.2.3 Asia-Pacific Pertuzumab Market Forecast (2021-2025)
12.2.4 South America Pertuzumab Market Forecast (2021-2025)
12.2.5 Middle East & Africa Pertuzumab Market Forecast (2021-2025)
12.3 Pertuzumab Market Forecast by Type (2021-2025)
12.3.1 Global Pertuzumab Sales Forecast by Type (2021-2025)
12.3.2 Global Pertuzumab Market Share Forecast by Type (2021-2025)
12.4 Pertuzumab Market Forecast by Application (2021-2025)
12.4.1 Global Pertuzumab Sales Forecast by Application (2021-2025)
12.4.2 Global Pertuzumab Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Pertuzumab Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pertuzumab by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pertuzumab Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 8. Novartis AG Pertuzumab Major Business
Table 9. Novartis AG Pertuzumab Total Revenue (USD Million) (2018-2019)
Table 10. Novartis AG SWOT Analysis
Table 11. Novartis AG Pertuzumab Product and Services
Table 12. Novartis AG Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. InvivoGen Basic Information, Manufacturing Base and Competitors
Table 14. InvivoGen Pertuzumab Major Business
Table 15. InvivoGen Pertuzumab Total Revenue (USD Million) (2018-2019)
Table 16. InvivoGen SWOT Analysis
Table 17. InvivoGen Pertuzumab Product and Services
Table 18. InvivoGen Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Pertuzumab Major Business
Table 21. Pfizer Pertuzumab Total Revenue (USD Million) (2018-2019)
Table 22. Pfizer SWOT Analysis
Table 23. Pfizer Pertuzumab Product and Services
Table 24. Pfizer Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Bio-Techne Basic Information, Manufacturing Base and Competitors
Table 26. Bio-Techne Pertuzumab Major Business
Table 27. Bio-Techne Pertuzumab Total Revenue (USD Million) (2018-2019)
Table 28. Bio-Techne SWOT Analysis
Table 29. Bio-Techne Pertuzumab Product and Services
Table 30. Bio-Techne Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Abnova Corporation Basic Information, Manufacturing Base and Competitors
Table 32. Abnova Corporation Pertuzumab Major Business
Table 33. Abnova Corporation Pertuzumab Total Revenue (USD Million) (2018-2019)
Table 34. Abnova Corporation SWOT Analysis
Table 35. Abnova Corporation Pertuzumab Product and Services
Table 36. Abnova Corporation Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Biocon Limited Basic Information, Manufacturing Base and Competitors
Table 38. Biocon Limited Pertuzumab Major Business
Table 39. Biocon Limited Pertuzumab Total Revenue (USD Million) (2018-2019)
Table 40. Biocon Limited SWOT Analysis
Table 41. Biocon Limited Pertuzumab Product and Services
Table 42. Biocon Limited Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Celltrion Basic Information, Manufacturing Base and Competitors
Table 44. Celltrion Pertuzumab Major Business
Table 45. Celltrion Pertuzumab Total Revenue (USD Million) (2018-2019)
Table 46. Celltrion SWOT Analysis
Table 47. Celltrion Pertuzumab Product and Services
Table 48. Celltrion Pertuzumab Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Global Pertuzumab Sales by Manufacturer (2018-2019) (K MT)
Table 50. Global Pertuzumab Revenue by Manufacturer (2018-2019) (USD Million)
Table 51. Global Pertuzumab Sales by Regions (2015-2020) (K MT)
Table 52. Global Pertuzumab Sales Market Share by Regions (2015-2020)
Table 53. Global Pertuzumab Revenue by Regions (2015-2020) (USD Million)
Table 54. North America Pertuzumab Sales by Countries (2015-2020) (K MT)
Table 55. North America Pertuzumab Sales Market Share by Countries (2015-2020)
Table 56. North America Pertuzumab Revenue by Countries (2015-2020) (USD Million)
Table 57. North America Pertuzumab Revenue Market Share by Countries (2015-2020)
Table 58. Europe Pertuzumab Sales by Countries (2015-2020) (K MT)
Table 59. Europe Pertuzumab Sales Market Share by Countries (2015-2020)
Table 60. Europe Pertuzumab Revenue by Countries (2015-2020) (USD Million)
Table 61. Asia-Pacific Pertuzumab Sales by Regions (2015-2020) (K MT)
Table 62. Asia-Pacific Pertuzumab Sales Market Share by Regions (2015-2020)
Table 63. Asia-Pacific Pertuzumab Revenue by Regions (2015-2020) (USD Million)
Table 64. South America Pertuzumab Sales by Countries (2015-2020) (K MT)
Table 65. South America Pertuzumab Sales Market Share by Countries (2015-2020)
Table 66. South America Pertuzumab Revenue by Countries (2015-2020) (USD Million)
Table 67. South America Pertuzumab Revenue Market Share by Countries (2015-2020)
Table 68. Middle East & Africa Pertuzumab Sales by Countries (2015-2020) (K MT)
Table 69. Middle East & Africa Pertuzumab Sales Market Share by Countries (2015-2020)
Table 70. Middle East & Africa Pertuzumab Revenue by Countries (2015-2020) (USD Million)
Table 71. Middle East & Africa Pertuzumab Revenue Market Share by Countries (2015-2020)
Table 72. Global Pertuzumab Sales by Type (2015-2020) (K MT)
Table 73. Global Pertuzumab Sales Share by Type (2015-2020)
Table 74. Global Pertuzumab Revenue by Type (2015-2020) (USD Million)
Table 75. Global Pertuzumab Revenue Share by Type (2015-2020)
Table 76. Global Pertuzumab Sales by Application (2015-2020) (K MT)
Table 77. Global Pertuzumab Sales Share by Application (2015-2020)
Table 78. Global Pertuzumab Sales Forecast by Regions (2021-2025) (K MT)
Table 79. Global Pertuzumab Market Share Forecast by Regions (2021-2025)
Table 80. Global Pertuzumab Sales Forecast by Type (2021-2025) (K MT)
Table 81. Global Pertuzumab Market Share Forecast by Type (2021-2025)
Table 82. Global Pertuzumab Sales Forecast by Application (2021-2025)
Table 83. Global Pertuzumab Market Share Forecast by Application (2021-2025)
Table 84. Direct Channel Pros & Cons
Table 85. Indirect Channel Pros & Cons
Table 86. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Pertuzumab Picture
Figure 2. Global Sales Market Share of Pertuzumab by Type in 2019
Figure 3. Human Source Picture
Figure 4. Animal Source Picture
Figure 5. Pertuzumab Sales Market Share by Application in 2018
Figure 6. Hospital Picture
Figure 7. Medical Center Picture
Figure 8. Global Pertuzumab Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Pertuzumab Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Pertuzumab Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Pertuzumab Sales Market Share by Manufacturer in 2019
Figure 29. Global Pertuzumab Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Pertuzumab Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Pertuzumab Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 34. Global Pertuzumab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Pertuzumab Revenue Market Share by Regions (2015-2020)
Figure 36. Global Pertuzumab Revenue Market Share by Regions in 2018
Figure 37. North America Pertuzumab Sales and Growth Rate (2015-2020)
Figure 38. Europe Pertuzumab Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Pertuzumab Sales and Growth Rate (2015-2020)
Figure 40. South America Pertuzumab Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Pertuzumab Sales and Growth Rate (2015-2020)
Figure 42. North America Pertuzumab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Pertuzumab Sales Market Share by Countries (2015-2020)
Figure 44. North America Pertuzumab Sales Market Share by Countries in 2018
Figure 45. North America Pertuzumab Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Pertuzumab Revenue Market Share by Countries in 2018
Figure 47. United States Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 48. Canada Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 49. Mexico Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 50. Europe Pertuzumab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Pertuzumab Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Pertuzumab Revenue Market Share by Countries in 2019
Figure 53. Germany Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 54. UK Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 55. France Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 56. Russia Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 57. Italy Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 58. Asia-Pacific Pertuzumab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Pertuzumab Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Pertuzumab Revenue Market Share by Regions 2019
Figure 61. China Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Japan Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Korea Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 64. India Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 65. Southeast Asia Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 66. South America Pertuzumab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Pertuzumab Sales Market Share by Countries in 2019
Figure 68. South America Pertuzumab Revenue Market Share by Countries in 2019
Figure 69. Brazil Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Argentina Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 71. Middle East and Africa Pertuzumab Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Pertuzumab Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Pertuzumab Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Pertuzumab Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Egypt Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 77. Turkey Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 78. South Africa Pertuzumab Sales and Growth Rate (2015-2020) (K MT)
Figure 79. Global Pertuzumab Sales and Growth Rate (2021-2025) (K MT)
Figure 80. Global Pertuzumab Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Pertuzumab Market Forecast (2021-2025) (K MT)
Figure 82. Europe Sales Pertuzumab Market Forecast (2021-2025) (K MT)
Figure 83. Asia-Pacific Sales Pertuzumab Market Forecast (2021-2025) (K MT)
Figure 84. South America Sales Pertuzumab Market Forecast (2021-2025) (K MT)
Figure 85. Middle East & Africa Sales Pertuzumab Market Forecast (2021-2025) (K MT)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel